492 related articles for article (PubMed ID: 19210879)
21. Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis.
Murchison AP; Gilbert ME; Bilyk JR; Eagle RC; Pueyo V; Sergott RC; Savino PJ
Am J Ophthalmol; 2012 Oct; 154(4):722-9. PubMed ID: 22809782
[TBL] [Abstract][Full Text] [Related]
22. Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features.
González-Gay MA; Blanco R; Sánchez-Andrade A; Vázquez-Caruncho M
J Rheumatol; 1997 Nov; 24(11):2166-70. PubMed ID: 9375879
[TBL] [Abstract][Full Text] [Related]
23. Temporal artery biopsy for suspected giant cell arteritis: a retrospective analysis.
Üsküdar Cansu D; Üsküdar Teke H; Korkmaz C
Rheumatol Int; 2021 Oct; 41(10):1803-1810. PubMed ID: 33156359
[TBL] [Abstract][Full Text] [Related]
24. Varicella zoster virus triggers the immunopathology of giant cell arteritis.
Gilden D; Nagel MA
Curr Opin Rheumatol; 2016 Jul; 28(4):376-82. PubMed ID: 27224742
[TBL] [Abstract][Full Text] [Related]
25. [Giant cell arteritis and polymyalgia rheumatica: diagnosis and evolution of 90 cases].
Rivero Puente A; Berasategui Calderón JI; Murie Carrillo De Albornoz JM; Rivero Marcotegui M; García-Bragado Acín F
An Med Interna; 2001 Apr; 18(4):191-4. PubMed ID: 11496538
[TBL] [Abstract][Full Text] [Related]
26. The role of unilateral temporal artery biopsy.
Hall JK; Volpe NJ; Galetta SL; Liu GT; Syed NA; Balcer LJ
Ophthalmology; 2003 Mar; 110(3):543-8; discussion 548. PubMed ID: 12623818
[TBL] [Abstract][Full Text] [Related]
27. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis.
Baldursson O; Steinsson K; Björnsson J; Lie JT
Arthritis Rheum; 1994 Jul; 37(7):1007-12. PubMed ID: 8024610
[TBL] [Abstract][Full Text] [Related]
28. [Giant cell arteritis. A study of 191 patients].
Armona J; Rodríguez-Valverde V; González-Gay MA; Figueroa M; Fernández-Sueiro JL; Blanco R; Martínez-Taboada V
Med Clin (Barc); 1995 Dec; 105(19):734-7. PubMed ID: 8523954
[TBL] [Abstract][Full Text] [Related]
29. Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study.
Muratore F; Cavazza A; Boiardi L; Lo Gullo A; Pipitone N; Germanò G; Bisagni A; Cimino L; Salvarani C
Arthritis Care Res (Hoboken); 2016 Jun; 68(6):865-70. PubMed ID: 26415044
[TBL] [Abstract][Full Text] [Related]
30. Giant cell arteritis and polymyalgia rheumatica. Review for the otolaryngologist.
Ferguson BJ; Allen NB; Farmer JC
Ann Otol Rhinol Laryngol; 1987; 96(4):373-9. PubMed ID: 3619280
[TBL] [Abstract][Full Text] [Related]
31. Non-giant cell arteritis of the temporal artery presenting as the polymyalgia rheumatica-temporal arteritis syndrome.
Lesser RS; Aledort D; Lie JT
J Rheumatol; 1995 Nov; 22(11):2177-82. PubMed ID: 8596167
[TBL] [Abstract][Full Text] [Related]
32. Effect of biopsy length on the rate of positive temporal artery biopsies.
Breuer GS; Nesher R; Nesher G
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S10-3. PubMed ID: 19646339
[TBL] [Abstract][Full Text] [Related]
33. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis.
Narváez J; Bernad B; Roig-Vilaseca D; García-Gómez C; Gómez-Vaquero C; Juanola X; Rodriguez-Moreno J; Nolla JM; Valverde J
Semin Arthritis Rheum; 2007 Aug; 37(1):13-9. PubMed ID: 17360027
[TBL] [Abstract][Full Text] [Related]
34. Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients.
Chmelewski WL; McKnight KM; Agudelo CA; Wise CM
Arch Intern Med; 1992 Aug; 152(8):1690-5. PubMed ID: 1497403
[TBL] [Abstract][Full Text] [Related]
35. Temporal artery bruits in a patient with giant cell arteritis.
Persellin ST; Cohen MD; Ginsburg WW; Calamia KT; Waldorf JC; Khoor A
J Rheumatol; 2003 Jan; 30(1):191-2. PubMed ID: 12508411
[TBL] [Abstract][Full Text] [Related]
36. Implication of the age in the clinical spectrum of giant cell arteritis.
Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S16-22. PubMed ID: 18799048
[TBL] [Abstract][Full Text] [Related]
37. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50.
Martínez-Taboada VM; Blanco R; Armona J; Uriarte E; Figueroa M; Gonzalez-Gay MA; Rodriguez-Valverde V
Clin Rheumatol; 2000; 19(1):73-5. PubMed ID: 10752506
[TBL] [Abstract][Full Text] [Related]
38. Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study.
Delaval L; Samson M; Schein F; Agard C; Tréfond L; Deroux A; Dupuy H; Garrouste C; Godmer P; Landron C; Maurier F; le Guenno G; Rieu V; Desblache J; Durel CA; Jousselin-Mahr L; Kassem H; Pugnet G; Queyrel V; Swiader L; Blockmans D; Sacré K; Lazaro E; Mouthon L; Aumaître O; Cathébras P; Guillevin L; Terrier B;
Arthritis Rheumatol; 2021 Feb; 73(2):286-294. PubMed ID: 32951354
[TBL] [Abstract][Full Text] [Related]
39. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.
Myklebust G; Gran JT
Br J Rheumatol; 1996 Nov; 35(11):1161-8. PubMed ID: 8948307
[TBL] [Abstract][Full Text] [Related]
40. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
